Medical Testing

Pfizer Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year--CEO

Submitted by mike kraft on

Pfizer CEO Says Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year Being able to take an at-home antiviral would be a “game changer,” according to Bourla. Tommy Beer Forbes
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

New studies say Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults

Submitted by mike kraft on

Pfizer and Moderna vaccines reduce risk for Covid-19 hospitalization by 94% among older adults, study shows The Pfizer/BioNTech and Moderna Covid-19 vaccines were found in the real world to be 94% effective against Covid-19 hospitalization among fully vaccinated adults ages 65 and older in the United States, according to a new US Centers for Disease Control and Prevention study. By <a href="/profiles/joshua-berlinger">Joshua Berlinger</a>, <a href="/profiles/jessie-yeung">Jessie Yeung</a>, <a href="/profiles/brett-mckeehan">Brett McKeehan</a>, <a href="/profiles/kara-fox">Kara Fox</a&gt
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Vaccinations
Contagion
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

New MIT research: Risk of contracting COVID-19 indoors the same at 6ft and 60ft

Submitted by mike kraft on

MIT researchers: Risk of contracting COVID-19 indoors the same at 6ft The risk of contracting COVID-19 indoors is the same when socially distanced 6 feet apart and 60 feet apart, researchers at the Massachusetts Institute of Technology (MIT) say. Jordan Williams TheHill

The risk of contracting COVID-19 indoors is the same when socially distanced 6 feet apart and 60 feet apart, researchers at the Massachusetts Institute of Technology (MIT) say.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

COVID-19 can damage the brain, but without infecting it, study suggests

Submitted by mike kraft on

COVID-19 damages brain without infecting it, study suggests Brain abnormalities could explain the confusion and delirium of severe COVID-19. CIDRAP

Although SARS-CoV-2 probably does not infect the brain, it can damage it significantly, a new study of autopsies of 41 COVID-19 patients finds.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

British scientists launch study to see to what extent coronavirus victims can get reinfected

Submitted by mike kraft on

New UK challenge trial studies if people can catch coronavirus again British scientists on Monday launched a trial which will deliberately expose participants who have already had COVID-19 to the coronavirus again to examine immune responses and see if people get reinfected. Reuters Reuters
Country / Region Tags: 
Global
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Data
Medical Testing
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

In Depth: Possible explanations for the rare blood clots after Johnson & Johnson vaccination

Submitted by mike kraft on

The race to untangle the secrets of rare, severe blood clots after Johnson & Johnson vaccination Making sense of rare, possibly related adverse events after vaccination can be notoriously tricky, but in this case, U.S. health officials have a blueprint. Carolyn Y. Johnson Washington Post

...

Country / Region Tags: 
Canada
Europe
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Vaccinations
Complexity
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

EU regulators find possible links between J&J shots and blot clots; still support the overall benefits

Submitted by mike kraft on

EU regulator finds link between J&J shot and blood clots LONDON (AP) — Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson &amp; Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine's benefits still outweighed the very small risks of recipients developing the unusual clots. The European Medicines Agency said a warning about the rare blood clots should be added to labels for Johnson &amp; Johnson’s COVID-19 vaccine.
Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

No new blood clotting cases reported to CDC over Johnson & Johnson vaccine

Submitted by mike kraft on

No new blood clotting cases over Johnson & Johnson vaccine, CDC says No new blood clotting cases have been confirmed after initial reports of such cases led federal regulators to recommend that states temporarily stop administering the Johnson & Johnson coronavirus vaccine. YahooNews
 
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Study indicates that having COVID does not mean future immunity

Submitted by mike kraft on

Having COVID doesn’t guarantee immunity, study of Marine recruits finds Ten percent of Marine recruits who had COVID antibodies got COVID again during basic training. Karen Jowers Marine Corps Times
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Vaccinations
Demographics
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Biden administration designating $1.7B for tracking, combating COVID-19 variants

Submitted by mike kraft on

Biden administration investing $1.7B into tracking, combating President Biden’s administration on Friday announced its plans to invest $1.7 billion into tracking and combating COVID-19 variants as new strains make up about half of all infections across the Justine Coleman TheHill
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Mutations
Public Health
Vaccinations
Contagion
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Medical Testing